← Eichor
Study identifier: NCT03507673 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction

Condition: Infertility  ·  Sponsor: University of Luebeck

PhaseN/A
Planned participants1200
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

Rationale: The hormone progesterone has different functions. In pregnancy, it is vital for maintenance thereof. In early pregnancy, progesterone is synthesized by the Corpus luteum (CL). Its production shifts from the CL to the placenta after several gestational weeks. This process is termed luteoplacental shift. Still, the exact time point of the luteoplacental shift remains unknown. Furthermore, the characteristics of placental progesterone increase and its relevance for the course of pregnancy has not been studied so far. Furthermore, recent studies have shown an influence of abnormal vaginal microbiota on the likelihood to achieve and maintain pregnancy. Little is known about possible crosslinks between endocrinology and vaginal/endometrial microbiota which is why this study aims to investigate possible associations of such kind. Objective: The primary objective of this study is to evaluate the time point of the luteoplacental shift in patients achieving pregnancy after transfer of cryopreserved embryos subsequently to IVF/ICSI cycles. Secondary objectives are to study the characteristics of the placental progesterone increase and its function as a predictor of the course and development of pregnancies and to study vaginal/endometrial microbiota at baseline and changes associated with shift into luteal phase and early pregnancy and how this potentially relates to pregnancy outcome. Study Design: Prospective, multi-center, observational clinical cohort study. For the…

This description comes directly from the study's public registry record.

Talk to the study team

Georg Griesinger, MD  ·  +49451 50577810  ·  georg.griesinger@uni-luebeck.de

Tanja Eggersmann, MD  ·  +49451 50577810  ·  tanja.eggersmann@uksh.de

Always discuss trial participation with your own doctor first.

Locations (5)

IVF-SAARSaarbrücken, Saarland, GermanyRecruiting
Universitäres Kinderwunschzentrum LübeckLübeck, Schleswig-Holstein, GermanyRecruiting
Universitätsklinikum Düsseldorf,UniKiDDüsseldorf, GermanyRecruiting
Universitäres KinderwunschzentrumKiel, GermanyRecruiting
University of LuebeckLübeck, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03507673